Although Ctnnb1 mutations are uncommon in human colon cancer, Smad4 mutations are associated with poor-prognosis, recurrence and resistance to treatment in colorectal cancer patients32,33 and found mutated in 13% of CACs4. Here, CTNNB1 is linked to colonic neoplasm.